Endocrine Abstracts

Vasopressin receptor 2 antagonist (V2RA) provide treatment option for patients with hyponatraeamia in the context of syndrome of inappropriate antidiuretic hormone secretion (SIADH).We report the results of seven patients (six males, one female, average age 65.7) with hyponatraemia secondary to SIADH treated with V2RA (Tolvaptan) in years 2011–2013. Six patients had underlying diagnosis of lung cancer, one patient was diagnosed with sarcoidosis. Fou...